期刊文献+

组织因子与急性冠脉综合征研究进展 被引量:1

Tissue Factor in Acute Coronary Syndrome
下载PDF
导出
摘要 组织因子作为FⅦ/FⅦa的细胞膜表面受体,是外源性凝血系统的关键因子,组织因子通过介导凝血激活形成血栓。动脉粥样硬化斑块破裂处血栓形成是急性冠脉综合征的主要原因,其临床后果的严重性决定于血栓的范围和进展。急性冠脉综合征时循环单核细胞和微颗粒表达组织因子,促进全身的促凝活性。动脉粥样硬化斑块中巨噬细胞、平滑肌细胞、血管内皮细胞表达组织因子,不稳定性斑块中组织因子表达和活性较稳定性斑块更高。组织因子通路抑制物是内源性组织因子抑制物,对调剂血栓形成有重要作用。现就目前组织因子与急性冠脉综合征研究进展作一综述。 Tissue factor (TF) is a receptor for factor FⅦ/FⅦa on a cell surface. It is an important initiator of the exdogenous coagulation cascade, and TF activates exdogenous coagulation cascade and causes thrombosis. The formation of thrombosis at the site of atherosclerotic plaque disruption is the principle cause of acute coronary syndrome. The severity of the clinical consequences is determined by the extent and progression of thrombus. In acute coronary syndromes, circulating monocytes and microparticles indicate TF and contribute to systemic procoagulant activity. Macrophages, smooth muscle cells, and endothelial cells can be an induced indication of TF in atherosclerotie plaques, and rates of TF expression and activity are higher in unstable plaques than in stable plaques. Tissue factor pathway inhibitor ( TFP1) is the endogenous inhibitor of TF and the role of TFP1 is important for regulating the thrombus formation. This article discusses the role of TF in acute coronary syndrome.
出处 《心血管病学进展》 CAS 2006年第3期317-321,共5页 Advances in Cardiovascular Diseases
关键词 组织因子 组织因子通路抑制物 急性冠脉综合征 tissue factor tissue factor pathway inhibitor acute coronary syndrome
  • 相关文献

参考文献34

  • 1Tremoli E,Camera M,Toschi V,et al.Tissue factor in atherosclerosis[J].Atherosclerosis,1999,144:273-283.
  • 2Ruf W.The interaction of activated factor Ⅶ with tissue factor:insight into the mechanism of cofactor-mediated activation of activated factor Ⅶ[J].Blood Coagul Fibrinolysis,1998,9:S73-S78.
  • 3McVey JH.Tissue factor pathway[J].Baillieres Best Pract Res Clin Haematol,1999,12:361-372.
  • 4Schecter AD,Spirn B,Rossikhina M,et al.Release of active tissue factor by human arterial smooth muscle cells[J].Circ Res,2000,87:126-132.
  • 5Corseaux D,le Tourneau T,Six I,et al.Enhanced monocyte tissue factor re-sponse after experimental balloon angioplasty in hypercholesterolemic rabbit:in-hibition with dietary L-arginine[J].Circulation,1998,98:1776-1782.
  • 6Siddiqui FA,Desai H,Amirkhosravi A,et al.The presence and release of tissue factor from human platelets[J].Platelets,2002,13:247-253.
  • 7Broze GJ Jr.Tissue factor pathway inhibitor and the revised theory of coagulation[J].Ann Rev Med,1995,46:103-112.
  • 8Hansen JB,Svensson B,Olsen R,et al.Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro[J].Thromb Haemost,2000,83:937-943.
  • 9Lupu C,Goodwin CA,Westmuckett AD,et al.Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae.Regulatory mechanism of the anticoagulant properties of the endothelium[J].Arterioscler Thromb Vasc Biol,1997,17:2964-2974.
  • 10Hamik A,Setiadi H,Bu G,et al.Down-regulation of monocyte tissue factor mediated by tissue factor pathway inhibitor and the low density lipoprotein receptor-related protein[J].J Biol Chem,1999,274:4962-4969.

同被引文献27

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部